Cancer is the #2 cause of death in the United States costing the American economy a whopping $107 billion each year. Cancer drugs alone cost around $20 billion a year but that number will grow substantially to $30 billion by 2003 and even higher in the future. There are currently 175 new cancer products being developed by numerous companies. Technology Investor Magazine research indicates that the following six companies have the best shot of finding new blockbuster cancer drugs: Genentech (DNA), Human Genome Sciences (HGSI), IDEC Pharmaceuticals (IDPH), Medarex (MEDX), Millennium Pharmaceuticals (MLNM) and Protein Design Labs (PDLI). April 7, 2001: Four companies that have cancer vaccines in Phase III trials ? they are AVI BioPharma (AVII), Biomira (BIOM), Dendreon (DNDN) and Progenics (PGNX). The Cancer Drug List also includes other companies that may cash in on the tremendous amount of money that is spent on this terrible disease if they develop their own blockbuster drugs. You might be interested in our broader Drug Stock List, Biotech List or Pharmaceutical Stock List.
The Cancer Drug List

AEZS AGEN AMGN AVXT AZN BIIB BIOM BMY CELG CTIC EXEL GERN HRBR IMGN JNJ LGND ONCY OXGN PDLI PGNX PPHM SGEN SRPT QLTI VICL

through VICL

Let me see a chart at Big Charts

Let me search for more news
SEARCH YAHOO NEWS


No warranty or guarantee is given as to the completeness or thoroughness of these lists.
Please do your own due diligence.

  ( Disclaimer ) ( Contact us ) ( About us ) ( Advertise with us ) ( Search Site )